etoposide has been researched along with o-(chloroacetylcarbamoyl)fumagillol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bo, J; Chen, S; Cheng, H; Liu, J; Liu, Y; Wan, J; Wang, J; Yang, F; Yang, J; Zhou, GC | 1 |
Fujimura, T; Hamada, Y; Haraguchi, F; Katsuoka, K; Ma, G; Masuzawa, M; Sakurai, Y; Tamauchi, H | 1 |
3 other study(ies) available for etoposide and o-(chloroacetylcarbamoyl)fumagillol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Identification, structural properties and chelating capacity of miltipolone as a broad-spectrum inhibitor to cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Diterpenes; Humans; Iron; Iron Chelating Agents; Isomerism; Models, Molecular; Molecular Conformation; Tropolone; Water | 2011 |
Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cell Division; Cyclohexanes; Endothelium, Vascular; Etoposide; Hemangiosarcoma; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; O-(Chloroacetylcarbamoyl)fumagillol; Prednisolone; Reference Values; Sesquiterpenes; Skin Neoplasms; Tumor Cells, Cultured | 2000 |